Rabesec 20 mg Tablet (10 Tab)

Cipla Ltd.(Gd)

Generic Name: Rabeprazole 20mg

OUT OF STOCK

MRP Rs. 102.32
Non Returnable

Medicine Information

About Rabesec 20 mg Tablet:

Rabesec 20 mg Tablet is indicated for the treatment of gastroesophageal reflux disease, gastric ulcer, and Zollinger-Ellison syndrome.

Each enteric-coated Rabesec 20 mg Tablet contains Rabeprazole Sodium 20 mg.

Rabeprazole is a proton pump inhibitor that suppresses gastric acid secretion by the inhibition of H+/K+-ATPase enzyme at the secretory surface of the gastric parietal cells. By this action, it prevents the production of acid in the stomach.

Use of Rabesec 20 mg Tablet:

Rabesec 20 mg Tablet is used to reduce the excessive acid production in the stomach. It is prescribed for the treatment of the following conditions:

  • Gastroesophageal reflux disease (GERD).
  • Excessive acidic condition of the stomach such as Zollinger-Ellison syndrome.
  • Damaged esophagus, which is caused by stomach acid (Erosive esophagitis).
  • Gastric ulcer, which is either caused by Helicobacter pylori (H. pylori) infection or induced by drugs.

Usage Direction of Rabesec 20 mg Tablet:

  • Rabesec 20 mg Tablet is intended for oral use only, in a dose and direction as prescribed by the Physician.
  • Rabesec 20 mg Tablet should be swallowed whole.
  • Do not crush or chew the tablet.
  • Do not skip or stop the medicine without the Physician’s advice.
  • Do not consume more than the prescribed quantity.

Precaution & Related information of Rabesec 20 mg Tablet:

  • If hypersensitive or allergic to Rabesec 20 mg Tablet, inform the physician immediately.
  • If found any other complications, inform the physician immediately.
  • The Physician should be well informed when concomitant consumption of this tablet with any other medicines or supplements.
  • Consult with the Physician during pregnancy & lactation.
  • Keep all medicines out of reach of children.

Storage condition of Rabesec 20 mg Tablet:

  • Store below 25°C. Protected from light & moisture.